Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 205

    1.

    Does intensive cholesterol lowering increase the risk of diabetes?

    Kostapanos MS, Milionis HJ, Elisaf MS.

    Int J Clin Pract. 2009 Dec;63(12):1809. No abstract available. PMID: 19930338 [PubMed - in process]Related articles

    2.

    Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome.

    Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN.

    Curr Pharm Des. 2009;15(29):3446-62.PMID: 19860690 [PubMed - in process]Related articles

    3.

    Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.

    Kostapanos MS, Milionis HJ, Agouridis AD, Rizos CV, Elisaf MS.

    Int J Clin Pract. 2009 Sep;63(9):1308-13.PMID: 19691613 [PubMed - in process]Related articles

    4.

    Are the pleiotropic effects of telmisartan clinically relevant?

    Rizos CV, Elisaf MS, Liberopoulos EN.

    Curr Pharm Des. 2009;15(24):2815-32. Review.PMID: 19689352 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study.

    Tzovaras VT, Psychogios NG, Kostara CE, Bairaktari ET, Elisaf MS.

    NMR Biomed. 2009 Jul 10. [Epub ahead of print]PMID: 19593759 [PubMed - as supplied by publisher]Related articles

    6.

    VISFATIN/PBEF and Atherosclerosis-Related Diseases.

    Filippatos TD, Randeva HS, Derdemezis CS, Elisaf MS, Mikhailidis DP.

    Curr Vasc Pharmacol. 2010 Jan 1. [Epub ahead of print]PMID: 19485930 [PubMed - as supplied by publisher]Related articles

    7.

    Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival.

    Milionis HJ, Giannopoulos S, Kosmidou M, Panoulas V, Manios E, Kyritsis AP, Elisaf MS, Vemmos K.

    Neurology. 2009 May 26;72(21):1816-22.PMID: 19470963 [PubMed - indexed for MEDLINE]Related articles

    8.

    Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis.

    Panoulas VF, Douglas KM, Smith JP, Metsios GS, Elisaf MS, Nightingale P, Kitas GD.

    Clin Exp Hypertens. 2009 Apr;31(2):93-104.PMID: 19330599 [PubMed - indexed for MEDLINE]Related articles

    9.

    Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

    Kostapanos MS, Milionis HJ, Filippatos TD, Christogiannis LG, Bairaktari ET, Tselepis AD, Elisaf MS.

    J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):5-13.PMID: 19246334 [PubMed - indexed for MEDLINE]Related articles

    10.

    Statin pleiotropy against renal injury.

    Kostapanos MS, Liberopoulos EN, Elisaf MS.

    J Cardiometab Syndr. 2009 Winter;4(1):E4-9.PMID: 19245508 [PubMed - indexed for MEDLINE]Related articles

    11.

    How safe is the use of thiazolidinediones in clinical practice?

    Rizos CV, Elisaf MS, Mikhailidis DP, Liberopoulos EN.

    Expert Opin Drug Saf. 2009 Jan;8(1):15-32. Review.PMID: 19236215 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia.

    Nakou ES, Filippatos TD, Kiortsis DN, Derdemezis CS, Tselepis AD, Mikhailidis DP, Elisaf MS.

    Expert Opin Pharmacother. 2008 Dec;9(18):3151-8.PMID: 19040336 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of hormonal treatment on lipids in patients with cancer.

    Filippatos TD, Liberopoulos EN, Pavlidis N, Elisaf MS, Mikhailidis DP.

    Cancer Treat Rev. 2009 Apr;35(2):175-84. Epub 2008 Nov 14. Review.PMID: 19013720 [PubMed - indexed for MEDLINE]Related articles

    14.

    Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality.

    Liberopoulos EN, Florentin M, Mikhailidis DP, Elisaf MS.

    Expert Opin Drug Saf. 2008 Nov;7(6):717-25. Review.PMID: 18983218 [PubMed - indexed for MEDLINE]Related articles

    15.

    Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

    Lagos KG, Filippatos TD, Tsimihodimos V, Gazi IF, Rizos C, Tselepis AD, Mikhailidis DP, Elisaf MS.

    Lipids. 2009 Jan;44(1):9-16. Epub 2008 Oct 28.PMID: 18956219 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pathophysiology and management of fluid and electrolyte disturbances in patients on chronic dialysis with severe hyperglycemia.

    Tzamaloukas AH, Ing TS, Siamopoulos KC, Raj DS, Elisaf MS, Rohrscheib M, Murata GH.

    Semin Dial. 2008 Sep-Oct;21(5):431-9. Review.PMID: 18945331 [PubMed - indexed for MEDLINE]Related articles

    17.

    Significant improvement of axillary artery stenosis in a 67 year-old woman with giant cell arteritis.

    Papadopoulos CG, Voulgari PV, Zioga A, Miltiadous GA, Nicolopoulos P, Elisaf MS, Drosos AA.

    Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S151-2. No abstract available. PMID: 18799073 [PubMed - indexed for MEDLINE]Related articles

    18.

    The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview.

    Nakou ES, Liberopoulos EN, Milionis HJ, Elisaf MS.

    Curr Vasc Pharmacol. 2008 Oct;6(4):258-70. Review.PMID: 18855714 [PubMed - indexed for MEDLINE]Related articles

    19.

    Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis.

    Panoulas VF, Douglas KM, Smith JP, Taffé P, Stavropoulos-Kalinoglou A, Toms TE, Elisaf MS, Nightingale P, Kitas GD.

    Endothelium. 2008 Jul-Aug;15(4):203-12.PMID: 18663623 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study.

    Derdemezis C, Filippatos T, Tselepis A, Mikhailidis D, Elisaf M.

    Expert Opin Pharmacother. 2008 Aug;9(11):1829-37.PMID: 18627322 [PubMed - indexed for MEDLINE]Related articles

    21.

    Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

    Kostapanos MS, Milionis HJ, Lagos KG, Rizos CB, Tselepis AD, Elisaf MS.

    Eur J Pharmacol. 2008 Aug 20;590(1-3):327-32. Epub 2008 Jun 7.PMID: 18585701 [PubMed - indexed for MEDLINE]Related articles

    22.

    Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes.

    Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

    Expert Opin Pharmacother. 2008 Jul;9(10):1705-20. Review.PMID: 18570604 [PubMed - indexed for MEDLINE]Related articles

    23.

    Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.

    Nakou E, Filippatos TD, Liberopoulos EN, Tselepis AD, Kiortsis DN, Mikhailidis DP, Elisaf MS.

    Expert Opin Pharmacother. 2008 Jul;9(10):1629-39.PMID: 18570597 [PubMed - indexed for MEDLINE]Related articles

    24.

    The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia.

    Nakou ES, Filippatos TD, Georgoula M, Kiortsis DN, Tselepis AD, Mikhailidis DP, Elisaf MS.

    Curr Med Res Opin. 2008 Jul;24(7):1919-29. Epub 2008 May 29.PMID: 18513463 [PubMed - indexed for MEDLINE]Related articles

    25.

    An overview of the extra-lipid effects of rosuvastatin.

    Kostapanos MS, Milionis HJ, Elisaf MS.

    J Cardiovasc Pharmacol Ther. 2008 Sep;13(3):157-74. Epub 2008 May 6. Review.PMID: 18460672 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pleiotropic effects of thiazolidinediones.

    Rizos CV, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

    Expert Opin Pharmacother. 2008 May;9(7):1087-108. Review.PMID: 18422468 [PubMed - indexed for MEDLINE]Related articles

    27.

    Fibrate-associated adverse effects beyond muscle and liver toxicity.

    Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

    Curr Pharm Des. 2008;14(6):574-87. Review.PMID: 18336300 [PubMed - indexed for MEDLINE]Related articles

    28.

    Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.

    Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

    Curr Med Res Opin. 2008 Apr;24(4):995-1009. Epub 2008 Feb 19. Review.PMID: 18291066 [PubMed - indexed for MEDLINE]Related articles

    29.

    Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients.

    Protopsaltis I, Korantzopoulos P, Milionis HJ, Koutsovasilis A, Nikolopoulos GK, Dimou E, Kokkoris S, Brestas P, Elisaf MS, Melidonis A.

    Stroke. 2008 Mar;39(3):1036-8. Epub 2008 Jan 31.PMID: 18239165 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Lipid abnormalities and cardiovascular risk in the elderly.

    Milionis HJ, Elisaf MS, Mikhailidis DP.

    Curr Med Res Opin. 2008 Mar;24(3):653-7. Epub 2008 Jan 23.PMID: 18218195 [PubMed - indexed for MEDLINE]Related articles

    31.

    Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.

    Milionis HJ, Kostapanos MS, Vakalis K, Theodorou I, Bouba I, Kalaitzidis R, Georgiou I, Elisaf MS, Siamopoulos KC.

    J Renin Angiotensin Aldosterone Syst. 2007 Dec;8(4):181-9.PMID: 18205097 [PubMed - indexed for MEDLINE]Related articles

    32.

    Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: review of published reports.

    Tzamaloukas AH, Ing TS, Siamopoulos KC, Rohrscheib M, Elisaf MS, Raj DS, Murata GH.

    J Diabetes Complications. 2008 Jan-Feb;22(1):29-37. Review.PMID: 18191075 [PubMed - indexed for MEDLINE]Related articles

    33.

    Ezetimibe-associated adverse effects: what the clinician needs to know.

    Florentin M, Liberopoulos EN, Elisaf MS.

    Int J Clin Pract. 2008 Jan;62(1):88-96. Review.PMID: 18173814 [PubMed - indexed for MEDLINE]Related articles

    34.

    Increased plasma visfatin levels in subjects with the metabolic syndrome.

    Filippatos TD, Derdemezis CS, Gazi IF, Lagos K, Kiortsis DN, Tselepis AD, Elisaf MS.

    Eur J Clin Invest. 2008 Jan;38(1):71-2. No abstract available. PMID: 18173555 [PubMed - indexed for MEDLINE]Related articles

    35.

    Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.

    Kostapanos MS, Milionis HJ, Saougos VG, Lagos KG, Kostara C, Bairaktari ET, Elisaf MS.

    J Cardiovasc Pharmacol Ther. 2007 Dec;12(4):292-7.PMID: 18172223 [PubMed - indexed for MEDLINE]Related articles

    36.

    Orlistat-associated adverse effects and drug interactions: a critical review.

    Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS.

    Drug Saf. 2008;31(1):53-65. Review.PMID: 18095746 [PubMed - indexed for MEDLINE]Related articles

    37.

    Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

    Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kita MD, Elisaf MS, Kitas GD.

    Rheumatology (Oxford). 2008 Jan;47(1):72-5.PMID: 18077493 [PubMed - indexed for MEDLINE]Related articles

    38.

    Sibutramine-associated adverse effects: a practical guide for its safe use.

    Florentin M, Liberopoulos EN, Elisaf MS.

    Obes Rev. 2008 Jul;9(4):378-87. Epub 2007 Nov 23. Review.PMID: 18034790 [PubMed - indexed for MEDLINE]Related articles

    39.

    Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: theoretical analysis.

    Tzamaloukas AH, Ing TS, Siamopoulos KC, Rohrscheib M, Elisaf MS, Raj DS, Murata GH.

    J Diabetes Complications. 2007 Nov-Dec;21(6):374-80.PMID: 17967710 [PubMed - indexed for MEDLINE]Related articles

    40.

    Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis.

    Panoulas VF, Douglas KM, Milionis HJ, Nightingale P, Kita MD, Klocke R, Metsios GS, Stavropoulos-Kalinoglou A, Elisaf MS, Kitas GD.

    J Hum Hypertens. 2008 Mar;22(3):177-82. Epub 2007 Oct 25.PMID: 17960169 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia.

    Kostapanos MS, Derdemezis CS, Filippatos TD, Milionis HJ, Kiortsis DN, Tselepis AD, Elisaf MS.

    Eur J Pharmacol. 2008 Jan 14;578(2-3):249-52. Epub 2007 Oct 2.PMID: 17931620 [PubMed - indexed for MEDLINE]Related articles

    42.

    A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.

    Kostapanos MS, Milionis HJ, Filippatos TD, Nakou ES, Bairaktari ET, Tselepis AD, Elisaf MS.

    Clin Ther. 2007 Jul;29(7):1403-14.PMID: 17825691 [PubMed - indexed for MEDLINE]Related articles

    43.

    Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.

    Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD.

    Rheumatology (Oxford). 2007 Sep;46(9):1477-82. Epub 2007 Aug 17.PMID: 17704521 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Should a statin be prescribed to every patient with heart failure?

    Tsouli SG, Liberopoulos EN, Goudevenos JA, Mikhailidis DP, Elisaf MS.

    Heart Fail Rev. 2008 Jun;13(2):211-25. Epub 2007 Aug 12. Review.PMID: 17694432 [PubMed - indexed for MEDLINE]Related articles

    45.

    Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.

    Panoulas VF, Milionis HJ, Douglas KM, Nightingale P, Kita MD, Klocke R, Elisaf MS, Kitas GD.

    Rheumatology (Oxford). 2007 Sep;46(9):1466-70. Epub 2007 Jul 21.PMID: 17644822 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

    Milionis HJ, Filippatos TD, Derdemezis CS, Kalantzi KJ, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS.

    Eur J Neurol. 2007 Jul;14(7):762-9.PMID: 17594332 [PubMed - indexed for MEDLINE]Related articles

    47.

    Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.

    Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS.

    Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):207-10. Epub 2007 Jun 13.PMID: 17570651 [PubMed - indexed for MEDLINE]Related articles

    48.

    Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

    Filippatos TD, Derdemezis CS, Kiortsis DN, Tselepis AD, Elisaf MS.

    J Endocrinol Invest. 2007 Apr;30(4):323-6.PMID: 17556870 [PubMed - indexed for MEDLINE]Related articles

    49.

    Analysis of antihypertensive effects of statins.

    Milionis HJ, Liberopoulos EN, Elisaf MS, Mikhailidis DP.

    Curr Hypertens Rep. 2007 Jun;9(3):175-83. Review.PMID: 17519121 [PubMed - indexed for MEDLINE]Related articles

    50.

    Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics.

    Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET.

    NMR Biomed. 2008 Mar;21(3):195-207.PMID: 17474139 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...